三友化工(600409.SH):海水淡化及濃海水綜合利用項目正在商談項目用地事宜
格隆匯12月6日丨三友化工(600409.SH)在投資者交流會上表示,高端電子化學品一期即年產2500t/a電子級氯化氫、6000t/a電子級氨、6000t/a電子級氨水、15000t/a電子級硫酸項目前期審批全部辦理完成,已開展土建施工。曹妃甸精細化工一期即年產4萬噸氯化亞碸、5萬噸氯乙酸、9.8萬噸燒鹼項目完成廠前區全部設計,基礎施工已基本完成,正在進行機電儀廠房、備品備件庫主體框架結構施工。海水淡化及濃海水綜合利用項目正在商談項目用地事宜。有機硅三期即20萬噸有機硅單體項目建設有序推進,目前已完成主裝置管道水壓試驗,高壓配電室送電,全面開展主裝置區單機調試。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.